The LAMISIL DIRECT brand, founded in 2007 (Switzerland), from 2951 sister brands and 17477 competing brands. The LAMISIL DIRECT brand is owned by NOVARTIS N, a company listed in Zurich. Its International Securities Identification Number (ISIN) is CH0012005267. LAMISIL DIRECT is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(LAMISIL DIRECT)
over 5 years*
CHF 99.86